Inotiv, Inc. Announces First Quarter Fiscal 2023 Financial Results
February 13, 2023 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Announces Fourth Quarter and Full Year Fiscal 2022 Financial Results
January 10, 2023 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Announces Additional Site Consolidation Plan in the U.S., Intent to Consult with Employee Representatives for a Proposed Consolidation of Certain European and U.K. Sites, and Update on Site Optimization Plans in Process
November 29, 2022 16:55 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Announces Third Quarter Fiscal 2022 Financial Results
August 10, 2022 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Envigo Reaches Agreement with the U.S. Department of Justice and the U.S. Department of Agriculture to Resolve Civil and Administrative Complaints
July 18, 2022 08:33 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., July 18, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Inotiv, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – NOTV
July 13, 2022 16:52 ET
|
The Rosen Law Firm PA
NEW YORK, July 13, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Inotiv, Inc. (NASDAQ: NOTV) between September 21, 2021 and...
Inotiv, Inc. Announces Site Closures and Consolidation Plans
June 13, 2022 20:10 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., June 13, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Announces Second Quarter Fiscal 2022 Financial Results
May 12, 2022 17:18 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., May 12, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Mice Model Market is estimated to be US$ 2.77 billion by 2030 with a CAGR of 6.10% during the forecast period - By PMI
May 02, 2022 09:52 ET
|
PMI
Covina, May 02, 2022 (GLOBE NEWSWIRE) -- Chronic diseases are becoming more common, and there is a growing demand for mice models in cancer research to better understand genetics. In addition,...
Inotiv, Inc. Announces First Quarter Fiscal 2022 Financial Results
February 10, 2022 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...